Veracity for expecting parents

NIPT is a non-invasive prenatal test which analyzes cell-free DNA  in the mother’s blood to identify genetic syndromes such as trisomies and sex chromosome aneuploidies in the fetus.

VERACITY is a new generation non-invasive prenatal test which accurately detects Down syndrome, Edwards syndrome and Patau syndrome, three of the most common fetal genetic disorders as well as other syndromes caused by X and Y chromosome aneuploidies. VERACITY also provides the option to know the gender of the baby.

Non-invasive prenatal testing is important because it provides a safe and accurate way to test the baby before birth for genetic disorders, the most common of which is Down syndrome. Before the introduction of this revolutionary test, the options to test for Down syndrome were either screening methods like ultrasound combined with other lab testing which have low accuracy (approximately 80-95%) or high accuracy prenatal diagnosis that uses invasive methods [e.g. amniocentesis or chorionic villi sampling (CVS)] which have 0.5% risk for miscarriage. VERACITY is a new generation non-invasive prenatal test that has significantly greater accuracy (>99%) and no risk for miscarriage.

Down syndrome, Edwards syndrome and Patau syndrome are genetic disorders caused by chromosomal trisomies. Down syndrome is caused by an extra copy of chromosome 21 whereas Edwards syndrome and Patau syndrome are caused by an extra copy of chromosome 18 and chromosome 13, respectively. Down syndrome is characterized by intellectual impairment and congenital abnormalities. Down syndrome occurs approximatel in 1 in 700 pregnancies but is more frequent in pregnancies in women over 35. Edwards syndrome and Patau syndrome are less common occurring in 1 in 3000 and 1 in 10000 pregnancies, respectively. Edwards and Patau syndromes are characterized by severe congenital abnormalities and rarely survive past the first year of life.

Ask your doctor about using VERACITY to detect these fetal trisomies.

Sex chromosome aneuploidies are genetic diseases caused by the presence or absence of a sex chromosome. The 23rd pair of chromosomes determine the sex of an individual. Women have two X chromosomes and men have one X and one Y chromosome. There are four major sex chromosome aneuploidies:

• Turner syndrome is characterized by the presence of a single X chromosome.
• Triple X syndrome is characterized by the presence of three X chromosomes.
• Klinefelter syndrome is characterized by the presence of two X chromosomes and one Y chromosome.
• Jacob syndrome is characterized by the presence of one X chromosome and two Y chromosomes.

Ask your doctor about using VERACITY to detect these fetal chromosomal aneuploidies.

VERACITY is a new generation non-invasive prenatal with unparalleled accuracy. VERACITY can be done for all singleton pregnancies after the 10th week of pregnancy and pregnancies conceived through in-vitro fertilization (IVF).

The high accuracy of VERACITY has been demonstrated in several clinical validation studies using hundreds of samples. VERACITY is fast, providing results to your doctor in a few days upon sample receipt to our laboratory. VERACITY is a safe test for both the mother and the fetus because it is performed using a simple blood draw.

VERACITY requires a blood draw which is perfomed by your doctor or healthcare provider. The blood sample is sent to our laboratory and the results are provided to your doctor in few days. Your doctor or healthcare provider will discuss your VERACITY results and provide counseling.

VERACITY is a new generation targeted non-invasive prenatal test. Its unique state-of-the-art design that confers unparalled accuracy also makes it a highly affordable test for the detection of fetal chromosomal aneuploidies. Please contact your healthcare provider regarding the cost of VERACITY and payment options in your country.

Please contact your doctor or healthcare provider for additional information.